A Candidate Respiratory Syncytial Virus (RSV) Prefusion F Protein Investigational Vaccine (rsvpref3 OA) is Immunogenic when Administered in Adults ≥ 60 Years of Age: Results at 6 Months after Vaccination

T. Schwarz, S. Hwang, P. Ylisastigui, C. Liu, K. Takazawa, M. Yono, J. Ervin, C. Andrews,C. Fogarty, T. Eckermann, D. Collete, M. De Heusch,N. De Schrevel, B. Salaun, M. Lievens,C. Marechal, P. Nakanwagi,V Hulstrom

PNEUMOLOGIE（2023）

Cited 0|Views0

Key words

Respiratory Syncytial Virus

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined